Can Caplin point become the next pharma giant? Caplin Point Fundamental Analysis
- Course to learn everything about money management: https://www.sahilbhadviya.in/s/store/courses/description/Everything-about-money-management
-For daily stock market update on Instagram: https://instagram.com/sahilbhadviya_?igshid=1mvrux9m5hdjf
-Linkedin: https://www.linkedin.com/in/sahil-bhadviya-1b871234/
- Quora: https://www.quora.com/profile/Sahil-Bhadviya
- Telegram: https://t.me/s/sahilbhadviya
Disclaimer: This video is only for education purpose. Consult your financial Advisor before investing your money.
Time stamp
0:00 Introduction
2:08 Company and its product portfolio
5:26 Leadership
5:57 Competitive Strength of Caplin Point
7:00 Key Risk
7:59 Key growth driver of Pharma sector
8:44 Caplin Point Future Growth
10:00 Financials
11:31 Valuations
11:51 Conclusion
In this video we have done Caplin Point fundamental analysis to understand if Caplin Point is the next Pharma Giant. We have covered the company and its product portfolio, leadership, competitive strength, key risk, competitors, key driver of pharma sector, Caplin point growth strategy and financials to understand if Caplin Point is fundamentally strong company or not. Then we have done the valuation analysis of Caplin point to decide if it is worth investing in Caplin point at current level.
About the Company
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 and set up a manufacturing facility at Pondicherry. Thereafter, the Company expanded its product range and increased its production capacity. Company focused on the emerging markets of Latin America, Caribbean and Southern Africa and is today one of the leading suppliers of Pharmaceuticals in these regions, with over 2800 product licenses across the globe.
Caplin point has also entered regulated markets such as US through its Subsidiary Caplin Steriles Limited. Caplin Point has been selected on Forbes Asia’s “200 Best Under a Billion” list for three consecutive years (2014, 2015 & 2016), and was recently awarded “The Emerging Company of 2018” by Economic Times Family Business Awards.
#Caplinpoint #fundamentalanalysis #stockmarketindia #caplinpointanalysis
Видео Can Caplin point become the next pharma giant? Caplin Point Fundamental Analysis канала Sahil Bhadviya
-For daily stock market update on Instagram: https://instagram.com/sahilbhadviya_?igshid=1mvrux9m5hdjf
-Linkedin: https://www.linkedin.com/in/sahil-bhadviya-1b871234/
- Quora: https://www.quora.com/profile/Sahil-Bhadviya
- Telegram: https://t.me/s/sahilbhadviya
Disclaimer: This video is only for education purpose. Consult your financial Advisor before investing your money.
Time stamp
0:00 Introduction
2:08 Company and its product portfolio
5:26 Leadership
5:57 Competitive Strength of Caplin Point
7:00 Key Risk
7:59 Key growth driver of Pharma sector
8:44 Caplin Point Future Growth
10:00 Financials
11:31 Valuations
11:51 Conclusion
In this video we have done Caplin Point fundamental analysis to understand if Caplin Point is the next Pharma Giant. We have covered the company and its product portfolio, leadership, competitive strength, key risk, competitors, key driver of pharma sector, Caplin point growth strategy and financials to understand if Caplin Point is fundamentally strong company or not. Then we have done the valuation analysis of Caplin point to decide if it is worth investing in Caplin point at current level.
About the Company
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 and set up a manufacturing facility at Pondicherry. Thereafter, the Company expanded its product range and increased its production capacity. Company focused on the emerging markets of Latin America, Caribbean and Southern Africa and is today one of the leading suppliers of Pharmaceuticals in these regions, with over 2800 product licenses across the globe.
Caplin point has also entered regulated markets such as US through its Subsidiary Caplin Steriles Limited. Caplin Point has been selected on Forbes Asia’s “200 Best Under a Billion” list for three consecutive years (2014, 2015 & 2016), and was recently awarded “The Emerging Company of 2018” by Economic Times Family Business Awards.
#Caplinpoint #fundamentalanalysis #stockmarketindia #caplinpointanalysis
Видео Can Caplin point become the next pharma giant? Caplin Point Fundamental Analysis канала Sahil Bhadviya
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Why IOL Chemicals & Pharmaceutical so cheap? IOLCP fundamental analysisWhy Motherson Sumi crashed 20% today? Big Announcement for shareholders!3 MidCap Stocks to accumulate after recent correction for Long Term Wealth Creation 🔥Subex - Phoenix rising from Ashes? Subex fundamental analysisCan Newgen become the next IT/Software multibagger? Newgen Software Fundamental AnalysisTop 10 smallcap stocks in India | Smallcap stocks in India with immense growth potentialCan Laurus Lab become the next Pharma Giant? Laurus Lab Fundamental AnalysisCAPLIN POINT CORP AV 10MNTSTata Teleservices (TTML) - A multibagger or trap? 100x return in last 2 years!Top 3 Technology Mutual Funds for 2022How to shortlist quality stocks in 2 minutes | Screener | EnglishHow to check if a stock is overvalued or undervalued? | What is PE Ratio? What is PEG Ratio?Top 8 stocks where you can invest blindly | Best stocks in India for long term investmentDon't make this financial blunder! | Biggest Financial MistakePolyplex : A smallcap superstock? Polyplex fundamental analysisWhat is the future of Praj Industries? Praj Industries stock fundamental analysisTop 15 monopoly stocks of India | Monopoly stocks - Part 1Top 10 stocks in my portfolio and their returnCan this Specialty Chemical company give multibagger returns? Rossari Biotech Fundamental Analysis